Best Seller
Outline star
Outline star
Outline star
Outline star
Outline star
Filled star
Filled star
Filled star
Filled star
Filled star
(1184)

resM® GLP-1 Support Postbiotic

Weight Support*
Reduce Cravings*
Healthy Blood Sugar Support*

Metabolic health isn't just about calories. If you are constantly battling cravings or food noise, resM was built for you: a postbiotic that supports your body's own GLP-1 pathway, the signal behind appetite & fullness, so meals feel like enough.*

Product BadgeProduct Badge

Start your Routine

Choose your formulas

Weight Loss Over 8 Weeks in a Randomized, Double-Blind, Placebo-Controlled Study*¹

Metabolism markers

Select a marker to see the results.

Tested against placebo, so the routine you start today is backed by a real comparison, in one capsule a day.*

Tested against placebo, so the routine you start today is backed by a real comparison, in one capsule a day.*

Results that showed up across the group, not just for a lucky few, with one simple capsule a day.*

Results that showed up across the group, not just for a lucky few, with one simple capsule a day.*

Learn More

Real people. Real resM results.

See why resM has become part of the daily routine for people working on their weight.*

After After
Before Before

*Individual results may vary. Photos shared by real customers.

Our Scientific Advisory Board

Meet the physician-scientists and researchers behind our formulas.

Vivek Lal, MD, FAAP

Vivek Lal, MD, FAAP

Founder & CEO, resbiotic

Amit Gaggar, MD, PhD

Amit Gaggar, MD, PhD

Chief Medical Officer

Kara Siedman, RDN, CDCES

Kara Siedman, RDN, CDCES

Director of Partnerships

Thea Nicola, MD, PhD, MBA

Thea Nicola, MD, PhD, MBA

Director, Lab Operations

Your Questions Answered

Study References

FDA disclaimer
  1. FDA disclaimer

    Footnote *: These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.

Human clinical studies(1)
  1. Human Clinical Trial

    Footnote 1: Based on an 8-week randomized, double-blind, placebo-controlled clinical trial of resM® in 80 adults with BMI 25 to 40 taking 1 capsule daily. Individual results may vary. resM® is not a GLP-1 receptor agonist drug and contains no synthetic GLP-1.

Consumer studies(2)
  1. Preclinical Study

    Footnote 2: Results observed in preclinical human cellular studies of the finished resM® formula. resM® contains no synthetic GLP-1 and is not a GLP-1 receptor agonist drug.

  2. resM+ resG Consumer Study

    Footnote 5: Based on a 60-day prospective, single-arm, open-label consumer study of 20 participants taking resM® and resG prebeet® daily. 85% reported fewer energy crashes at day 60 and mean craving scores improved by approximately 24%. No control group. Individual results may vary.